Amneal Pharmaceuticals, Inc.AMRXNASDAQ
Loading
Cost of Revenue Over TimeStrong
Percentile Rank100
3Y CAGR+10.3%
5Y CAGR+6.9%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
+10.3%/yr
vs +10.7%/yr prior
5Y CAGR
+6.9%/yr
Recent acceleration
Acceleration
-0.4pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.4x
Solid growth
Streak
4 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $1.91B | +7.4% |
| 2024 | $1.77B | +15.9% |
| 2023 | $1.53B | +7.7% |
| 2022 | $1.42B | +7.3% |
| 2021 | $1.32B | -2.9% |
| 2020 | $1.36B | +7.1% |
| 2019 | $1.27B | +34.5% |
| 2018 | $946.59M | +86.5% |
| 2017 | $507.48M | +20.6% |
| 2016 | $420.77M | - |